Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cholangiocarcinoma
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• LY4337713

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ovarian Neoplasms, Breast Neoplasms | Phase 1 | Status: RECRUITING